Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites

- Liu, Zheng, Martin, Jennifer H., Hatzimihalis, Athena, Campbell, Ian, Crowley, Simone, Beale, Phillip J., Karapetis, Christos S., Price, Timothy, Burge, Mathew E., Michael, Michael, Liauw, Winston, Mclachlan, Sue-Anne, Link, Emma, Matera, Anetta, Thompson, Michael, Jefford, Michael, Hicks, Rod J., Cullinane, Carleen

Improving outcomes for people with progressive cancer: interrupted time series trial of a needs assessment intervention

- Waller, Amy, Girgis, Afaf, Johnson, Claire, Lecathelinais, Christophe, Sibbritt, David, Forstner, Dion, Liauw, Winston, Currow, David C.

Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study

- Daniels, Benjamin, Luckett, Tim, Holliday, Simon, Liauw, Winston, Lovell, Melanie, Phillips, Jane, Rowett, Debra, John, Toby Newton, Tervonen, Hanna, Pearson, Sallie-Anne

Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners

- Luckett, Tim, Newton-John, Toby, Phillips, Jane, Holliday, Simon, Giannitrapani, Karleen, Powell-Davies, Gawaine, Lovell, Melanie, Liauw, Winston, Rowett, Debra, Pearson, Sallie-Anne, Raymond, Bronwyn, Heneka, Nicole, Lorenz, Karl